Cost-effectiveness of dutasteride-tamsulosin combination therapy for the treatment of symptomatic benign prostatic hyperplasia: A Canadian model based on the CombAT trial

INTRODUCTION: Benign prostatic hyperplasia (BPH) is common in men 50 years old and older. The main treatment options are alpha-blockers (such as tamsulosin), which reduce symptoms, and 5-alpha reductase inhibitors (such as dutasteride), which reduce symptoms and slow disease progression. Clinical st...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Ismaila, Afisi, Walker, Anna, Sayani, Amyn, Laroche, Bruno, Nickel, J. Curtis, Posnett, John, Su, Zhen
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Canadian Medical Association 2013
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3699085/
https://ncbi.nlm.nih.gov/pubmed/23826050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.12131
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items